Dose finding studies for therapies with late‐onset toxicities: A comparison study of designs-Reference-Cited by-同舟云学术

Dose finding studies for therapies with late‐onset toxicities: A comparison study of designs

Published:2022-10-17 Issue:30 Volume:41 Page:5767-5788
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statistics in Medicine

Author:

Barnett Helen¹²^ORCID,Boix Oliver³,Kontos Dimitris⁴,Jaki Thomas¹⁵^ORCID

Affiliation:

1. MRC Biostatistics Unit University of Cambridge Cambridge UK

2. Learning Development, Lancaster University Lancaster UK

3. Bayer AG Leverkusen Germany

4. ClinBAY Limassol Cyprus

5. Faculty of Informatics and Data Science, University of Regensburg Regensburg Germany

Funder

Medical Research Council Canada

NIHR

NIHR Cambridge Biomedical Research Centre

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.9593

Reference20 articles.

1. National Cancer Institute.Common terminology criteria for adverse events (CTCAE) v5.0; 2017.http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm.

2. Phase I Trials of Molecularly Targeted Agents: Should We Pay More Attention to Late Toxicities?

3. Shortening the Timeline of Pediatric Phase I Trials: The Rolling Six Design

4. Design and Analysis of Phase I Clinical Trials

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Joint TITE-CRM: A Design for Dose Finding Studies for Therapies with Late-Onset Safety and Activity Outcomes;Statistics in Biopharmaceutical Research;2024-04-17

2. Dose optimization for cancer treatments with considerations for late-onset toxicities;Clinical Trials;2024-04-09

3. Estimands in Oncology Early Clinical Development: Assessing the Impact of Intercurrent Events on the Dose-Toxicity Relationship;Statistics in Biopharmaceutical Research;2023-12-18

4. Early phase clinical trials in oncology: Realising the potential of seamless designs;European Journal of Cancer;2023-08